News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>JPM Sees Profit-Taking Actions in CN Pharma Sector as Entry Opportunity
Regarding yesterday's (23rd) hefty sell-off among Chinese biotech and pharmaceutical stocks, JPMorgan said in its report that it seemed to have been sparked by profit-taking de...
Reset
Send
The window will close in 5 seconds
<Research>JPM Sees Profit-Taking Actions in CN Pharma Sector as Entry Opportunity
Close
Recommend
56
Positive
86
Negative
55
 
 

Regarding yesterday's (23rd) hefty sell-off among Chinese biotech and pharmaceutical stocks, JPMorgan said in its report that it seemed to have been sparked by profit-taking decisions as a result of position adjustments rather than any fundamental deterioration.

JPMorgan considered this pullback as a good entry opportunity to build positions in China's healthcare sector ahead of the next wave of catalyst-driven upside. The broker preferred the biotech and CXO (clinical trial service providers) sub-sectors, with INNOVENT BIO (01801.HK)  -1.600 (-1.938%)    Short selling $247.89M; Ratio 28.194%   , SKB BIO (06990.HK)  +20.600 (+4.541%)    Short selling $111.06M; Ratio 18.469%   , WUXI APPTEC (02359.HK)  -1.000 (-0.763%)    Short selling $91.84M; Ratio 23.617%   , and WUXI XDC (02268.HK)  +1.550 (+2.780%)    Short selling $104.70M; Ratio 44.254%   as its top picks.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-22 16:25.)

Related News UBS Cuts ALI HEALTH (00241.HK) TP to HKD3.6 as Higher Investment Reduces Earnings Visibility

Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.